Luke Chen: VEXAS Syndrome – Uncovering Hidden Cases in Nova Scotia
Luke Chen, Hematologist at Dalhousie University, shared a post on LinkedIn about a recent article by Joey Fitzpatrick, published in QEII Foundation, adding:
“Thank you QEII Foundation for highlighting VEXAS in the latest issue of QEII Times.
The VEXAS (Vacuoles, E1 enzyme, X chromosome, autoinflammatory, somatic) syndrome was discovered in 2020 and typically appears in men over the age of 40 with protean manifestations such as relapsing polychondritis (ears and nose), cutaneous inflammation, high CRP, pulmonary disease, macrocytic cytopenias, vacuoles in bone marrow, and thrombosis, among other symptoms.
Often, high dose steroids are the only conventional treatment that controls the inflammation – but better therapies are available.
Statistically, there should be 75-80 cases in Nova Scotia … where are they?”
Title: QEII TIMES: Unlocking blood disease mysteries
Authors: Joey Fitzpatrick
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 8, 2026, 15:14Renzo Mancuso: Human Stem Cell Model Reveals Progenitor Fate in Tissue Macrophages
-
Oct 8, 2026, 15:01Yogesh Kumar Jain: The Gift Of Life Through Blood Donation
-
Oct 8, 2026, 14:49Christoph B. Olivier: DOACs Gain Ground in Post-MI Left Ventricular Thrombus Management
-
Oct 8, 2026, 14:46Cesar Garrido: WFH Partners with Tunisia to Expand Hemophilia Care and Treatment Access
-
Oct 8, 2026, 14:34Jan Hartmann: Special Series On Source Plasma Now Fully Published
-
Oct 8, 2026, 14:32Lachlan Dalli: Cross-Country Analysis of DOAC Adherence After Stroke
-
Oct 8, 2026, 14:23Bianca Constantin: Science And Clinical Experience At The RSH National Conference
-
Oct 8, 2026, 14:17Sudhanshi Raina: Predicting Germline Mutations in Aplastic Anemia Using Telomere Length
-
Oct 8, 2026, 14:10Rebecca Akpeloo: PE as an Overlooked Threat in Sickle Cell Disease